Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

PHASE2TerminatedINTERVENTIONAL
Enrollment

259

Participants

Timeline

Start Date

October 29, 2012

Primary Completion Date

September 26, 2016

Study Completion Date

January 3, 2017

Conditions
Liver Fibrosis Due to NASH
Interventions
BIOLOGICAL

Placebo

Placebo to match SIM intravenous infusion over 30 minutes every 2 weeks

BIOLOGICAL

SIM

Intravenous infusion over 30 minutes every 2 weeks

Trial Locations (59)

4129

Eugastro Gmbh, Leipzig

10016

New York University, New York

10032

Columbia University Medical Center, New York

10126

Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino

11030

North Shore University Health System, Manhasset

14203

State University Of New York at Buffalo, Buffalo

19104

University of Pennsylvania Hospital, Philadelphia

20089

Istituto Clinico Humanitas, Rozzano

20889

Walter Reed National Military Medical Center, Bethesda

21202

Mercy Medical Center, Baltimore

22908

University of Virginia Health Center, Charlottesville

23226

Bucheon St. Marys Hospital, Richmond

23298

Virginia Commonwealth University, Richmond

23502

Digestive and Liver Disease Specialists, Norfolk

23602

Liver Institute of Virginia, Newport News

24146

Gastroenterologisch-Hepatologisches Zentrum Kiel, Kiel

27710

Duke University Medical Center, Durham

28222

Hospital Universitario Puerta de Hierro, Majadahonda

29425

Medical University of South Carolina, Charleston

33136

University of Miami, Miami

33606

Tampa General Hospital, Tampa

37212

Vanderbilt University Medical Center, Nashville

38104

Methodist University Hospital, Memphis

39216

University of Mississippi Medical Center, Jackson

40202

University of Louisville, Louisville

41100

Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena

44106

University Hospitals Case Medical Center, Cleveland

46202

Indiana University School of Medicine, Division of Gastroenterology/Hepatology, Indianapolis

50325

Iowa Digestive Disease Center, Clive

55114

Minnnesota Gastroenterology, PA, Saint Paul

60611

Northwestern University, Chicago

63110

Saint Louis University Hospital, St Louis

67091

Fonds de Recherche Honoraires, Strasbourg

69317

Hôpital de la Croix Rousse, Lyon

70112

Tulane University, New Orleans

75012

Hospital Saint-Antoine, Paris

75013

CHU Pitié-Salpêtrière, Paris

76012

Texas Clinical Research Institute, Arlington

77030

St. Luke Episcopal Hospital, Houston

78215

Alamo Clinical Research Associates, San Antonio

78234

Brooke Army Medical Center, Fort Sam Houston

80045

University of Colorado, Denver, Aurora

84107

Intermountain Transplant Center, Murray

85054

Mayo Clinic Hospital, Phoenix

92103

University of California, San Diego (UCSD), San Diego

92118

Southern California Liver Centers, Coronado

94143

University of California San Francisco (UCSF), San Francisco

98101

Virginia Mason Medical Center, Seattle

98104

University of Washington, Seattle

01805

Lahey Clinic, Burlington

02905

University Gastroenterology, Providence

R3E 3P4

University of Manitoba, Winnipeg

B3H 2Y9

Dalhousie University, Halifax

M6H 3M1

Toronto Liver Centre, Toronto

00927

Fundacion De Investigacion, San Juan

08035

Hospital Vall D´Hebron, Barcelona

NW3 2QG

Royal Free Hospital, Pond Street, London

SE5 9RS

King's College Hospital NHS Trust, London

NG7 2UH

Nottingham University Hospitals Queen's Medical Centre, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY